Saturday November 28, 1998 - Question 8
Which of the following statements regarding neuroleptic malignant syndrome (NMS) is correct?
A. Neuroleptic malignant syndrome is a rare complication
of neuroleptic treatment.
B. The condition is characterized by a hypometabolic
state.
C. This syndrome is only associated with phenothiazine
neuroleptic treatment.
D. Neuroleptic malignant syndrome has not yet
been reported in non-psychotic patients receiving neuroleptics.
E. Neuroleptic malignant syndrome is more likely
to occur during the chronic phase of psychiatric illness in persons stabilized
on a medication regimen.